In 2015, the Cancer Genome Atlas (TCGA) evaluated 333 primary PC and concluded that alterations in DDR genes were common, as affected almost 20% of samples through mutations or deletions in BRCA1/2, CDK12, ATM, FANCD2, or RAD51C [20]. The gene discussed is BRCA1; the disease is pachyonychia congenita.